tiprankstipranks
Advertisement
Advertisement
Genscript Biotech’s Core Earnings Surge but Legend Impairment Drives 2025 Net Loss
PremiumCompany AnnouncementsGenscript Biotech’s Core Earnings Surge but Legend Impairment Drives 2025 Net Loss
2M ago
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
Premium
Company Announcements
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
2M ago
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
Premium
Company Announcements
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
2M ago
Genscript Biotech Updates RSU Schemes for Improved Governance
PremiumCompany AnnouncementsGenscript Biotech Updates RSU Schemes for Improved Governance
5M ago
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
Premium
Company Announcements
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
5M ago
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
Premium
Company Announcements
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
6M ago
GenScript Biotech’s Earnings Call Highlights Robust Growth
PremiumCompany AnnouncementsGenScript Biotech’s Earnings Call Highlights Robust Growth
9M ago
Genscript Biotech Reports Strong Revenue Growth Amid Strategic Investments
Premium
Company Announcements
Genscript Biotech Reports Strong Revenue Growth Amid Strategic Investments
9M ago
Genscript Biotech Reports Strong Revenue and Profit Growth in H1 2025
Premium
Company Announcements
Genscript Biotech Reports Strong Revenue and Profit Growth in H1 2025
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100